# Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)

> **NCT07687706** · PHASE3 · RECRUITING · sponsor: **Hanyang University Guri Hospital** · enrollment: 1524 (estimated)

## Conditions studied

- Ischemic Stroke
- Ischemic Stroke, Acute
- Transient Ischemic Attack (TIA)
- Cerebrovascular Disease
- Gastrointestinal Complication
- Gastrointestinal Bleeding

## Interventions

- **DRUG:** Tegoprazan 50 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07687706
- **Lead sponsor:** Hanyang University Guri Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 1524 (ESTIMATED)
- **Last updated:** 2026-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687706, "Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07687706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*